Welcome to our dedicated page for UBS ETRACS Alerian MLP Index ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.
UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.
For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.
On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.
UBS AG priced a preliminary offering of Trigger Autocallable Contingent Yield Notes linked to the common stock of Caterpillar Inc. The Notes mature on April 23, 2029, pay contingent coupons only if observation-date levels meet barriers, and may auto-call early if the underlying meets the initial level.
The Notes repay principal at maturity only if the final level is at or above a downside threshold; otherwise principal repayment is reduced proportionally to the underlying return. Payments remain subject to the creditworthiness of UBS. Trade and settlement are expected on April 17, 2026 and April 21, 2026, respectively.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Mattel, Inc. The Notes mature on April 21, 2027 and may pay periodic contingent coupons only if the underlying stock closes at or above a coupon barrier on scheduled observation dates. The Notes will be automatically called early if the underlying stock closes at or above the initial level on any pre-maturity observation date, in which case investors receive principal plus any contingent coupon on the call settlement date. If not called, repayment of principal at maturity is contingent: if the final level is below the downside threshold, investors suffer a loss equal to the underlying return and could lose all principal. Payments are unsecured obligations of UBS and depend on UBS's creditworthiness. The Notes are offered in minimum increments of 100 Notes at $10 per Note and have an estimated initial value of $9.78 as of the trade date.
UBS AG priced a preliminary offering of Trigger Autocallable Contingent Yield Notes linked to the common stock of Mattel, Inc. The Notes have a principal amount of $10 per Note, trade date April 17, 2026, settlement April 21, 2026 and maturity on or about April 21, 2027. Investors receive contingent coupons only when the underlying stock closing level meets or exceeds the coupon barrier on observation dates; early automatic call occurs if the underlying closes at or above the initial level on any pre-final observation date. If not called and the final level is below the downside threshold, principal repayment is reduced proportionally to the underlying return, and investors could lose a significant portion or all of their investment. Minimum initial investment is 100 Notes ($1,000). The estimated initial value range is $9.46–$9.71 per Note, and all payments remain subject to the creditworthiness of UBS AG.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to Boston Scientific common stock due April 21, 2027. The Notes pay contingent coupons only if the underlying meets the coupon barrier on observation dates and may be automatically called early if the underlying equals or exceeds the initial level on any observation date. If not called and the final level is below the downside threshold, principal repayment is reduced pro rata to the underlying return, potentially causing substantial or total loss. Payments depend on UBS creditworthiness. Trade date is April 17, 2026, settlement April 21, 2026, final valuation April 19, 2027, maturity April 21, 2027.
UBS AG offers Trigger Autocallable Contingent Yield Notes linked to Accenture plc common stock due April 21, 2027. The Notes may pay periodic contingent coupons only if the underlying closing level meets the coupon barrier on observation dates and can be automatically called early if the underlying equals or exceeds the initial level on any observation date. If not called, principal is repaid at maturity only if the final level is at or above the downside threshold; otherwise principal is reduced pro rata to the underlying return, potentially resulting in total loss. All payments are subject to UBS credit risk.
UBS AG offers Trigger Autocallable Contingent Yield Notes linked to the common stock of Boston Scientific Corporation, as described in a preliminary pricing supplement dated April 17, 2026. The Notes pay periodic contingent coupons only if the underlying's closing level meets or exceeds a coupon barrier on observation dates and are subject to automatic early call if the underlying meets or exceeds the initial level on an observation date prior to the final valuation date. If not called, principal repayment at maturity is contingent: if the final level is below a stated downside threshold, holders suffer a loss tied to the underlying return and could lose their entire investment. The Notes have a minimum investment of $1,000 (100 Notes at $10 per Note) and an estimated initial value range of $9.47 to $9.72 per Note. All payments, including any contingent coupons or principal, are subject to the creditworthiness of UBS.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Accenture plc, with final terms to be set on the trade date. The notes mature on April 21, 2027, have a principal amount of $10 per note and a minimum investment of 100 notes ($1,000). The preliminary pricing supplement shows a trade date of April 17, 2026 and settlement on April 21, 2026. Examples list an illustrative contingent coupon rate of 11.32% per annum and an estimated initial value range of $9.45 to $9.70 per note. The notes pay contingent coupons only if observation-date closing levels meet or exceed the coupon barrier, are subject to automatic early call if the underlying equals or exceeds the initial level on an observation date, and repay principal at maturity only if the final level is at or above a downside threshold (illustratively $60.00, or 60.00% of the initial level). If the final level is below that threshold, principal is reduced proportionally (an example shows a $3.60 payment per $10 note, a 61.17% loss in that scenario). All payments, including any contingent coupons or principal, are subject to UBS's creditworthiness.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to Oracle Corporation stock due April 21, 2027. The Notes pay periodic contingent coupons only if the underlying closing level on observation dates meets or exceeds a coupon barrier and may be automatically called early if the underlying reaches the initial level. If not called, principal repayment at maturity is contingent: full principal is paid if the final level is at or above the downside threshold; otherwise repayment is reduced pro rata to the underlying return, potentially resulting in substantial or total loss. All payments remain subject to UBS credit risk.
UBS AG priced a preliminary offering of Trigger Autocallable Contingent Yield Notes linked to Oracle Corporation stock due on or about April 21, 2027. The Notes pay a contingent coupon only when the underlying closing level is at or above a coupon barrier on observation dates and may be automatically called early if the underlying closes at or above the initial level on an observation date. If not called, principal repayment at maturity is contingent on the final level relative to a downside threshold; if the final level is below that threshold, investors will suffer a loss equal to the underlying return, potentially losing their entire investment. The offering has a minimum purchase of 100 Notes at $10 per Note and an estimated initial value range of $9.45 to $9.70 per Note as of the trade date.
UBS AG is offering $4,990,000 of Trigger Autocallable GEARS linked to the Bloomberg Commodity Index 3 Month. The securities have a $10 principal per security, a one-year observation date on April 22, 2027, and a maturity on April 17, 2031 unless automatically called.
If the underlying closes at or above the autocall barrier on the observation date, UBS will automatically call the securities and pay the call price equal to principal plus a 14.20% per annum call return (call price $11.42 per $10 security). If not called, maturity payoffs depend on the underlying return and an upside gearing of 1.3915; a final level below the downside threshold (50.00% of the initial level) exposes holders to losses of principal, potentially to zero. Any payments are subject to UBS credit risk. The estimated initial value per security was $9.70.